Abstract

This contract supports the preclinical, nonclinical, and clinical development (phase I and phase II) of Fludase(R) as a broad spectrum therapeutic agent for all annual and pandemic variations of influenza to enable the FDA submission of a biologics license application (BLA).

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI60015-3-0-1
Application #
7854756
Study Section
Project Start
2006-09-29
Project End
2011-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$9,999,863
Indirect Cost

  Institution

Name
Nexbio, Inc.
Department
Type
DUNS #
140600268
City
San Diego
State
CA
Country
United States
Zip Code
92121